Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies

被引:16
作者
Han, Lei [1 ,3 ]
Zong, Huifang [1 ]
Zhou, Yuexian [1 ]
Pan, Zhidi [1 ]
Chen, Jie [1 ]
Ding, Kai [1 ]
Xie, Yueqing [2 ]
Jiang, Hua [2 ]
Zhang, Baohong [1 ]
Lu, Huili [1 ]
Gilly, John [3 ]
Zhu, Jianwei [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Engn Res Ctr Cell & Therapeut Antibody, Minist Educ, Shanghai, Peoples R China
[2] Jecho Labs Inc, Frederick, MD USA
[3] Jecho Biopharmaceut Co Ltd, Tianjin, Peoples R China
关键词
Bispecific antibody; Protein engineering; Trans-splicing reaction; Split intein; Npu DnaE; EXPRESSION;
D O I
10.1016/j.ymeth.2018.10.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High product purity, preserving natural IgG architecture, and excellent production efficiency are highly desirable in bispecific antibody manufacturing. We have reported a platform called Bispecific Antibody by Protein Trans-Splicing (BAPTS) to synthesize BsAbs with natural human IgG structure and no chain mispairing. In the method, two antibody fragments carrying different target-specificities are separately expressed in mammalian cells and subsequently fused to form BsAbs by utilizing the trans-splicing property of the split intein Npu DnaE. The hinge region of antibody, a region with less functional impact, is selected for conjugating the two fragments. The method involves the following steps: (i) constructing five plasmids coding antibody components; (ii) separately expressing and purifying two antibody fragments A and B. Fragment A contains one Fab, "Knobs-intoHoles" mutations in the CH3 domain and NPU DnaE(c). Fragment B contains another Fab and NPU DnaE(N); (iii) mixing of fragments A and B under permissive reducing conditions in vitro to enable trans-splicing reaction; (iv) removing the reluctant to allow re-oxidation of disulfide bonds; (v) isolating BsAb product from unreacted precursors by affinity chromatography. The method allows correct assembly of two heavy and two light chains to form bispecific IgG antibodies in natural structure with no synthetic linkers. No chain mispairing was observed in the product by UPLC-MASS. In addition, the observed kinetics and low reaction activation energy confirmed that the trans-splicing is thermodynamically favored reaction. The BAPTS technology is feasible for industrial applications.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 21 条
[11]   Bispecific digoxigenin-binding antibodies for targeted payload delivery [J].
Metz, Silke ;
Haas, Alexander K. ;
Daub, Karin ;
Croasdale, Rebecca ;
Stracke, Jan ;
Lau, Wilma ;
Georges, Guy ;
Josel, Hans-Peter ;
Dziadek, Sebastian ;
Hopfner, Karl-Peter ;
Lammens, Alfred ;
Scheuer, Werner ;
Hoffmann, Eike ;
Mundigl, Olaf ;
Brinkmann, Ulrich .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (20) :8194-8199
[12]   Engineering split intein DnaE from Nostoc punctiforme for rapid protein purification [J].
Ramirez, Miguel ;
Valdes, Najla ;
Guan, Dongli ;
Chen, Zhilei .
PROTEIN ENGINEERING DESIGN & SELECTION, 2013, 26 (03) :215-223
[13]   Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients [J].
Ruf, Peter ;
Kluge, Michael ;
Jaeger, Michael ;
Burges, Alexander ;
Volovat, Constantin ;
Heiss, Markus Maria ;
Hess, Jurgen ;
Wimberger, Pauline ;
Brandt, Birgit ;
Lindhofer, Horst .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (06) :617-625
[14]   A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies [J].
Schaefer, Gabriele ;
Haber, Lauric ;
Crocker, Lisa M. ;
Shia, Steven ;
Shao, Lily ;
Dowbenko, Donald ;
Totpal, Klara ;
Wong, Anne ;
Lee, Chingwei V. ;
Stawicki, Scott ;
Clark, Robyn ;
Fields, Carter ;
Phillips, Gail D. Lewis ;
Prell, Rodney A. ;
Danilenko, Dimitry M. ;
Franke, Yvonne ;
Stephan, Jean-Philippe ;
Hwang, Jiyoung ;
Wu, Yan ;
Bostrom, Jenny ;
Sliwkowski, Mark X. ;
Fuh, Germaine ;
Eigenbrot, Charles .
CANCER CELL, 2011, 20 (04) :472-486
[15]   Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies [J].
Schaefer, Wolfgang ;
Regula, Joerg T. ;
Baehner, Monika ;
Schanzer, Juergen ;
Croasdale, Rebecca ;
Duerr, Harald ;
Gassner, Christian ;
Georges, Guy ;
Kettenberger, Hubert ;
Imhof-Jung, Sabine ;
Schwaiger, Manfred ;
Stubenrauch, Kay G. ;
Sustmann, Claudio ;
Thomas, Markus ;
Scheuer, Werner ;
Klein, Christian .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (27) :11187-11192
[16]   Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity [J].
Shatz, Whitney ;
Chung, Shan ;
Li, Bing ;
Marshall, Brett ;
Tejada, Max ;
Phung, Wilson ;
Sandoval, Wendy ;
Kelley, Robert F. ;
Scheer, Justin M. .
MABS, 2013, 5 (06) :872-881
[17]   Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies [J].
Spiess, Christoph ;
Merchant, Mark ;
Huang, Arthur ;
Zheng, Zhong ;
Yang, Nai-Ying ;
Peng, Jing ;
Ellerman, Diego ;
Shatz, Whitney ;
Reilly, Dorothea ;
Yansura, Daniel G. ;
Scheer, Justin M. .
NATURE BIOTECHNOLOGY, 2013, 31 (08) :753-+
[18]   Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair [J].
Strop, Pavel ;
Ho, Wei-Hsien ;
Boustany, Leila M. ;
Abdiche, Yasmina N. ;
Lindquist, Kevin C. ;
Farias, Santiago E. ;
Rickert, Mathias ;
Appah, Charles Takeshi ;
Pascua, Edward ;
Radcliffe, Teresa ;
Sutton, Janette ;
Chaparro-Riggers, Javier ;
Chen, Wei ;
Casas, Meritxell Galindo ;
Chin, Sherman Michael ;
Wong, Oi Kwan ;
Liu, Shu-Hui ;
Vergara, German ;
Shelton, Dave ;
Rajpal, Arvind ;
Pons, Jaume .
JOURNAL OF MOLECULAR BIOLOGY, 2012, 420 (03) :204-219
[19]   Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target [J].
Yu, Y. Joy ;
Zhang, Yin ;
Kenrick, Margaret ;
Hoyte, Kwame ;
Luk, Wilman ;
Lu, Yanmei ;
Atwal, Jasvinder ;
Elliott, J. Michael ;
Prabhu, Saileta ;
Watts, Ryan J. ;
Dennis, Mark S. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (84)
[20]  
Zhu J., 2013, UPDATE PRODUCTION RE